Details

Policy Statement: Clarifying the appropriate regulatory pathway for subsequent entry low molecular weight heparins - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 6, 2026 · edition #6
Timestamp: 2026-01-06T20:02:02.501Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/policy-statement-clarifying-appropriate-regulatory-molecular-weight-heparins.html?wbdisable=true
Replay URL: https://replay.healtharchive.ca/job-6/20260106200202/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/policy-statement-clarifying-appropriate-regulatory-molecular-weight-heparins.html?wbdisable=true#ha_snapshot=482834
ID: 482834
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots